Walleye Trading’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.54M | Buy |
+118,561
| New | +$6.42M | 0.01% | 989 |
|
|
2025
Q4 | – | Sell |
-8,206
| Closed | -$383K | – | 4528 |
|
|
2025
Q3 | $354K | Sell |
8,206
-9,863
| -55% | -$385K | ﹤0.01% | 2978 |
|
|
2025
Q2 | $694K | Buy |
+18,069
| New | +$690K | ﹤0.01% | 2438 |
|
|
2024
Q4 | – | Sell |
-870
| Closed | -$31.3K | – | 4387 |
|
|
2024
Q3 | $35.6K | Sell |
870
-4,130
| -83% | -$169K | ﹤0.01% | 3589 |
|
|
2024
Q2 | $193K | Buy |
+5,000
| New | +$210K | ﹤0.01% | 3111 |
|
|
2024
Q1 | – | Sell |
-26,195
| Closed | -$1.08M | – | 4997 |
|
|
2023
Q4 | $971K | Sell |
26,195
-27,316
| -51% | -$981K | ﹤0.01% | 2491 |
|
|
2023
Q3 | $1.94M | Buy |
+53,511
| New | +$1.9M | 0.01% | 1806 |
|
|
2020
Q3 | – | Sell |
-8,498
| Closed | -$426K | – | 4322 |
|
|
2020
Q2 | $433K | Sell |
8,498
-5,491
| -39% | -$282K | ﹤0.01% | 2383 |
|
|
2020
Q1 | $663K | Buy |
+13,989
| New | +$746K | 0.01% | 1628 |
|
|
2019
Q3 | – | Sell |
-5,400
| Closed | -$278K | – | 4163 |
|
|
2019
Q2 | $270K | Buy |
+5,400
| New | +$271K | ﹤0.01% | 2708 |
|
|
2019
Q1 | – | Sell |
-3,043
| Closed | -$152K | – | 4421 |
|
|
2018
Q4 | $145K | Sell |
3,043
-43,123
| -93% | -$2.12M | ﹤0.01% | 3657 |
|
|
2018
Q3 | $2.32M | Buy |
+46,166
| New | +$2.35M | 0.01% | 1183 |
|
|
2018
Q1 | – | Sell |
-3,845
| Closed | -$179K | – | 4581 |
|
|
2017
Q4 | $170 | Sell |
3,845
-407
| -10% | -$18.8K | ﹤0.01% | 3564 |
|
|
2017
Q3 | $216 | Buy |
+4,252
| New | +$216K | ﹤0.01% | 3167 |
|
|
2017
Q2 | – | Sell |
-15,566
| Closed | -$830K | – | 4666 |
|
|
2017
Q1 | $820 | Sell |
15,566
-8,031
| -34% | -$407K | 0.01% | 1810 |
|
|
2016
Q4 | $1.14M | Buy |
+23,597
| New | +$1.17M | 0.01% | 1419 |
|
|
2016
Q1 | – | Sell |
-15,566
| Closed | -$775K | – | 5519 |
|
|
2015
Q4 | $785K | Buy |
15,566
+3,022
| +24% | +$154K | 0.01% | 1463 |
|
|
2015
Q3 | $603K | Buy |
12,544
+4,553
| +57% | +$237K | 0.01% | 1415 |
|
|
2015
Q2 | $416K | Buy |
7,991
+489
| +7% | +$27.5K | ﹤0.01% | 1806 |
|
|
2015
Q1 | $433K | Buy |
7,502
+18
| +0.2% | +$1.03K | ﹤0.01% | 1598 |
|
|
2014
Q4 | $400K | Sell |
7,484
-61,838
| -89% | -$3.46M | ﹤0.01% | 1755 |
|
|
2014
Q3 | $3.98M | Buy |
69,322
+61,254
| +759% | +$3.76M | 0.05% | 200 |
|
|
2014
Q2 | $539 | Sell |
8,068
-32,509
| -80% | -$2.2M | 0.01% | 1210 |
|
|
2014
Q1 | $2.71K | Buy |
40,577
+18,083
| +80% | +$1.22M | 0.04% | 320 |
|
|
2013
Q4 | $1.5M | Sell |
22,494
-31,025
| -58% | -$2.01M | 0.01% | 831 |
|
|
2013
Q3 | $3.36M | Buy |
53,519
+43,737
| +447% | +$2.82M | 0.04% | 379 |
|
|
2013
Q2 | $611K | Buy |
+9,782
| New | +$621K | 0.01% | 1139 |
|
Other funds holding GSK
JEST
Walleye Trading's GSK Position: Q1 2026 in Review
Walleye Trading opened a new position in GSK (GSK) in Q1 2026: 118,561 shares worth $6.54M. The stake represents 0.01% of the portfolio and ranks #989 among its holdings. This is a return to the name: Walleye Trading previously reported a position in GSK as recently as Q3 2025.
Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Walleye Trading held 118,561 shares of GSK worth $6.54M as of Q1 2026.
- GSK was a new Walleye Trading position in Q1 2026.
- GSK made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #989 holding.
- Walleye Trading first reported a position in GSK in Q2 2013 and has held it in 27 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.